Head-to-head · Value Score
Vitara RX vs Nova MD
Two GLP-1 deals, scored on the same six factors. Vitara RX lands a Value Score of 91, Nova MD a 73. Here's who gives you the honest lower price — and where each one bites back.
Vitara RX
#4 · Grade A · Best Value
Est. first month
$99/mo
Save ~93% vs brand-nameNova MD
#178 · Grade C+ · Watch List
Est. first month
From $125/mo (3-month plan, compounded)
Save ~91% vs brand-nameThe verdict
Vitara RX takes it on Value Score, 91 to 73 — an est. $99/mo first month, with no teaser step-up baked in. Nova MD isn't out of it: Shoppers who want lowest 3-month compounded pricing with an explicit microdose program.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Vitara RX | Nova MD |
|---|---|---|
| Value Score | 91 (A) | 73 (C+) |
| Est. first month | $99/mo | From $125/mo (3-month plan, compounded) |
| Save vs brand-name | ~93% | ~91% |
| Semaglutide | $99/mo | From $125/mo (3-month plan, compounded) |
| Tirzepatide | $149/mo | From $199/mo (3-month plan, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | 49 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Vitara RX
VitaraRx is a direct-to-consumer telehealth marketplace offering compounded semaglutide and tirzepatide at flat per-drug pricing across all doses — no membership or hidden fees.
Why it's a deal
- Among the lowest flat pricing in the market — $99/mo semaglutide and $149/mo tirzepatide, all doses same price
- Names its 503A pharmacy partner (Manifest Pharmacy, Greer SC) — strong supply-chain transparency
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer
- Covers 49 states with an explicit state list, not vague "most states" language
The fine print
- No corporate legal entity disclosed — only the trade name "VitaraRx"
- No named medical director — all clinical decisions made by independent providers (marketplace model)
- All sales final — no medication returns
- Per-vial mg quantity isn't clearly disclosed, making price comparisons harder
- Doesn't ship to Alaska
Nova MD
Nova MD is a telehealth platform offering compounded semaglutide and tirzepatide on 1-month and 3-month plans, with an uncommon explicit microdose program for both molecules.
Why it's a deal
- On-page pricing published for all four SKUs (semaglutide and tirzepatide, 1- and 3-month)
- $125/mo semaglutide and $199/mo tirzepatide 3-month plans rank among the cheapest in the market
- $50 off first tirzepatide order shown publicly
- Explicit microdose / low-dose program for both semaglutide and tirzepatide
- Broader menu (sermorelin, NAD+, glutathione, enclomiphene) for longevity alongside GLP-1
The fine print
- Legal entity name and state of incorporation not disclosed
- Compounding pharmacy not named — only 'accredited facilities'
- LegitScript certification not confirmed (only 'Licensed US Providers' claims)
- Per-state availability not listed
- Compounded only — no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Vitara RX is ranked on the Vitara RX alternatives board, and the same list for the other side is on alternatives to Nova MD.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.